139 related articles for article (PubMed ID: 2731311)
21. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
Padrón F; Sanz J; Flórez J
Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
[No Abstract] [Full Text] [Related]
23. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
24. Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting.
Allan SG; Cornbleet MA; Lockhart SP; Warrington PS; Leonard RC; Smyth JF
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1481-4. PubMed ID: 6389147
[TBL] [Abstract][Full Text] [Related]
25. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
Stephens SH; Silvey VL; Wheeler RH
Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
[TBL] [Abstract][Full Text] [Related]
27. [Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients].
Kagami Y; Nishio M; Narimatsu N; Tomita M; Sakurai T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):807-10. PubMed ID: 2712578
[TBL] [Abstract][Full Text] [Related]
28. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
[TBL] [Abstract][Full Text] [Related]
29. Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.
Ell C; König HJ; Brockmann P; Domschke S; Domschke W
Oncology; 1985; 42(6):354-7. PubMed ID: 4069550
[TBL] [Abstract][Full Text] [Related]
30. The use of methylprednisolone and metoclopramide in control of emesis in patients receiving cis-platinum.
Benrubi GI; Norvell M; Nuss RC; Robinson H
Gynecol Oncol; 1985 Jul; 21(3):306-13. PubMed ID: 4040050
[TBL] [Abstract][Full Text] [Related]
31. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
[TBL] [Abstract][Full Text] [Related]
32. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
Donovitz GS; O'Quinn AG; Smith ML
Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
[TBL] [Abstract][Full Text] [Related]
33. Antiemetic combination for PAC (cisplatin-adriamycin-cyclophosphamide) chemotherapy-induced emesis in ovarian cancer.
Martin-Jimenez M; Diaz-Rubio E; Gonzalez Larriba JL; Sangro B
Eur J Gynaecol Oncol; 1987; 8(2):98-102. PubMed ID: 3552683
[TBL] [Abstract][Full Text] [Related]
34. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
[TBL] [Abstract][Full Text] [Related]
35. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
Navari RM; Province WS; Perrine GM; Kilgore JR
Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191
[TBL] [Abstract][Full Text] [Related]
36. Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin.
Kris MG; Cubeddu LX; Gralla RJ; Cupissol D; Tyson LB; Venkatraman E; Homesley HD
Cancer; 1996 Nov; 78(10):2193-8. PubMed ID: 8918414
[TBL] [Abstract][Full Text] [Related]
37. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
[TBL] [Abstract][Full Text] [Related]
38. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis.
Harman GS; Omura GA; Ryan K; Hainsworth JD; Cramer MB; Hahne WF
Cancer Chemother Pharmacol; 1996; 38(4):323-8. PubMed ID: 8674154
[TBL] [Abstract][Full Text] [Related]
40. High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichlorodiammineplatinum.
Luesley DM; Terry PB; Chan KK
Cancer Chemother Pharmacol; 1985; 14(3):250-2. PubMed ID: 4039634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
